The conference underscored the urgent need for genomic testing, AI-driven diagnostics, and interdisciplinary collaborations to reshape cancer treatment in India

AIIMS Jammu in collaboration with 4baseCare, an Illumina Accelerator Company hosted the Precision Oncology Expert Meet (POEM-2025). The event, held at the Convention Centre, AIIMS Jammu, brought together leading oncologists, scientists, and healthcare experts to discuss the latest advancements in genomics-driven personalised patient care.

The event was led by Prof (Dr) Shakti Kumar Gupta, Executive Director & CEO, AIIMS Jammu, alongside Hitesh Goswami, Founder and CEO, 4baseCare and Dr Poonam Sharma, Associate Professor & Head, Dept of Pathology, AIIMS Vijaypur, Jammu. Under their leadership, the conference underscored the urgent need for genomic testing, AI-driven diagnostics, and interdisciplinary collaborations to reshape cancer treatment in India.

Hitesh Goswami, CEO and Co-Founder, 4baseCare, said, “The recent inauguration of AIIMS Jammu’s Centre for Advanced Genomics & Precision Medicine, followed by POEM-2025, marks a significant milestone in India’s commitment to precision-driven, patient-centric oncology. As India moves towards a future where every cancer patient receives the right treatment at the right time, events like POEM-2025 set the stage for scientific breakthroughs to become clinical realities.” 

Key discussions: 

• Transforming Oncology Through Innovation- POEM-2025 hosted a series of panel discussions, case-based studies, and expert insights focused on leveraging advanced technology for better patient outcomes.
• Precision Oncology & Global Collaborations- Experts emphasized the importance of data-sharing and multidisciplinary approaches to ensure accurate and effective cancer treatments.
• International Perspectives- Precision Oncology in the Philippines- Global speakers, including Dr Catherine Sia Cheng Teh (Makati Medical Center, Philippines) and Dr Necy Saguisag Juat (LINCS, Philippines), highlighted the growing role of international cooperation in precision medicine. Leaders shared groundbreaking insights on the evolving role of CAR-T therapy, biomarker-driven treatments, and next-gen immunotherapies.
• Case-Based Panels on Breast & Head & Neck Cancers: Specialised discussions on tumour-specific precision medicine applications showcased real-world cases, demonstrating how genomic testing can drive more accurate, effective, and less toxic treatments.
• AI revolution in Precision Oncology:- Hitesh Goswami, CEO 4baseCare, discussed the soon to be launched- OncoTwin Insights, a groundbreaking AI-powered platform that is poised to transform cancer care. This innovative solution redefines how cancer treatments are personalised by integrating cutting-edge artificial intelligence, machine learning, and real-world clinical data.

POEM will be an annual event that will serve as a standard blueprint for the future—where data-driven, personalised cancer care becomes the standard, not the exception.